4-(2-Oxo-butyl)-benzamidine; hydrochloride, 95.0%, 1g

Benzenesulfonamide, N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-, 95%, 10mg

4-n-Butylchlorobenzene, 98%, 1g

6,8-Dimethoxy-4-methylquinoline>98.0%(GC)(T)5g

2-Amino-3-(3-cyanophenyl)propanoic acid hydrochloride, 97%, 250mg

1-Acetoxy-3-chloroacetone, 95.0%, 25g

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP), 10mL, >=99%, pour la synthèse peptidique

6-Bromo-2,4-dichloroquinoline, 95.0%, 5g

2-Cyano-5-methoxybenzoic acid methyl ester, 95.0%, 1g

PYRIDAZINE-3-CARBOXIMIDAMIDE HCL, 95.0%, 1g

2-(Trifluoromethyl)propenoic acid, 98.0%, 100g

2-(TERT-BUTOXYCARBONYL)-2-AZABICYCLO[2.1.1]HEXANE-4-CARBOXYLIC ACID, 95.0%, 500mg

(4-Isobutoxyphenyl)methanamine, 98%, 250mg